A recent study using TCGA RCC data demonstrated that differences in expression in specific checkpoint-related genes, such as PDCD1 (PD1) and CD247 (PDL1), correlated with patient survival within ccRCC cases (Chen et al., 2016). This evidence concerns the gene PDCD1 and renal cell carcinoma.